Is MoonLake Immunotherapeutics (MLTX) a Buy, Sell, or Hold?
NASDAQ : MLTX
MoonLake Immunotherapeutics — Competitors
$18.71 USD
-$1.17 (-5.89%)
- Volume
- 990.1K
- Average Volume
- 1.11M
- Market Capitalization
- $1.55B
- P/E Ratio
- -4.82
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $62.75
- Year Low
- $5.95
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.60
MLTX vs. The Competition
| Properties | MLTX | ABSI | AVBP | CTMX |
|---|---|---|---|---|
| Market Cap | $1.55B | $1.21B | $1.4B | $517.85M |
| Shares Outstanding | $82.62M | $169.4M | $46.57M | $160.82M |
| P/E Ratio | -4.82 | -8.59 | -8.49 | -8.91 |
| EPS | -3.61 | -0.77 | -3.22 | -0.33 |
| Day Low | 18.67 | 6.8501 | 29.3 | 3.13 |
| Day High | 19.65 | 7.47 | 31.12 | 3.274 |
| Year Low | 5.95 | 2.24 | 16.1 | 1.72 |
| Year High | 62.75 | 12.055 | 35.83 | 8.21 |
| Average Price 50 | 18.957 | 7.9293 | 31.0467 | 3.4398 |
| Average Price 200 | 15.99448 | 4.57433 | 25.1371 | 4.18983 |
| Volume | 990.1K | 2.85M | 773.88K | 2M |
| Average Volume | - | - | - | - |